glp 1 resistencia a la insulina GLP-1 y GIP: Las hormonas que están revolucionando el control del peso y diabetes GLP-1 y GIP: Las hormonas
Description
Random-effects models were employed for the pooled analysis, and heterogeneity was evaluated using the I2 statistic

GLP-1 based therapies led to statistically significant reductions in the serum levels of brain natriuretic peptide (40.16 [51.50, 28.81]
This systematic review and meta-analysis aims to update the evidence on the impact of GLP-1 RAs on EGD outcomes, evaluate the effect of concurrent colonoscopy (CLN) on GRC, and assess the influence of different GLP-1 RA agents on GRC

This promises to be an important brainstorm around peoples behavior beyond the pure clinical aspects of GLP-1s efficacy